LicianPro

Dave Rogers

Equity research analyst · Raymond James

Earnings calls

3

Nov 3, 2026 – Nov 3, 2026

Stocks asked about

3

Questions

3

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Dave Rogers asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 32:45
      “Obviously, getting more comfortable putting equity into the life science acquisitions that you've done probably tells us that you're also getting a little more comfortable with where pricing for lease deals is. So I'm kind of curious. In the quarter, you said negative five, six…”
    • 24:49
      “I know you don't really give a target in the outlook, but just given that you've gone from the two to the 13 operators now. How many of those operators do you want to continue to grow with? Or might they have another decent sized portfolio that they're operating where you can…”
    • 36:58
      “Your line is now open. Hey, Rick, good morning out there. I think you addressed this maybe a couple of questions ago, but maybe ask it in a different way. Forty some odd percent of your skilled expirations are kind of after 2035. And I think Ensign's been out there desiring to…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

Raymond James rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Dave Rogers. We do not use licensed rating databases.

No rating action by Raymond James on these stocks in the headlines we store yet.